BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Teva
Queensland Health
Boehringer Ingelheim
Covington
Citi
Medtronic
Deloitte
Harvard Business School
McKinsey

Generated: January 22, 2018

DrugPatentWatch Database Preview

ESTERIFIED ESTROGENS Drug Profile

« Back to Dashboard

Which patents cover Esterified Estrogens, and what generic alternatives are available?

Esterified Estrogens is a drug marketed by Pvt Form and Sandoz and is included in four NDAs.

The generic ingredient in ESTERIFIED ESTROGENS is estrogens, esterified. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the estrogens, esterified profile page.
Summary for ESTERIFIED ESTROGENS
Drug patent expirations by year for ESTERIFIED ESTROGENS

US Patents and Regulatory Information for ESTERIFIED ESTROGENS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pvt Form ESTERIFIED ESTROGENS estrogens, esterified TABLET;ORAL 083414-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz ESTERIFIED ESTROGENS estrogens, esterified TABLET;ORAL 085302-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pvt Form ESTERIFIED ESTROGENS estrogens, esterified TABLET;ORAL 083765-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pvt Form ESTERIFIED ESTROGENS estrogens, esterified TABLET;ORAL 085907-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Fish and Richardson
Fuji
Federal Trade Commission
Novartis
US Department of Justice
Cipla
Accenture
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot